SCHEMBL348920

SCHEMBL348920

OCCOc1[c]cccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
RECQL P46063 1/20 0.48
IDO1 P14902 1/20 0.39
GAA P10253 1/20 0.38
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NR1I2 O75469 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 1/20 0.32
MCHR1 Q99705 1/20 0.31
PDK2 Q15119 1/20 0.30
CYP19A1 P11511 1/20 0.30
CCNE2 O96020 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30
CYP3A4 P08684 1/20 0.30
DHPS P49366 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2762966 0.90 ALDH1A1 (0.38) ALDH1A1RECQLIDO1GAAMEN1
SCHEMBL11352154 0.89 KMT2A (0.40) ALDH1A1RECQLMEN1KMT2ASMN1; SMN2
SCHEMBL6238419 0.87 JAK2 (0.33) ALDH1A1RECQLGAASMN1; SMN2HTT
SCHEMBL27858367 0.86 CNR2 (0.35) ALDH1A1RECQLPDK2
SCHEMBL2008537 0.83 KCNH2 (0.32) ALDH1A1RECQL
SCHEMBL584941 0.83
SCHEMBL8598226 0.82 TDP1 (0.33) ALDH1A1RECQL
SCHEMBL188983 0.79 KDM4E (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2CYP19A1
SCHEMBL126227 0.79 ALDH1A1 (0.34) ALDH1A1GAAMEN1KMT2ASMN1; SMN2
SCHEMBL2458787 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154969-B1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES INC (US) 2019-10-09 EP claimed
US-10221197-B2 Phosphatidylinositol 3-kinase inhibitors GILEAD SCIENCES, INC. (US) 2019-03-05 US claimed
EP-3154969-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES, INC. (US) 2017-04-19 EP claimed
WO-2015191745-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES, INC. (US) 2015-12-17 WO claimed
US-8218931-B2 D 1413 HT radiation curable coatings for optical fiber DSM IP ASSETS B.V. (NL) 2012-07-10 US claimed
US-20100261765-A1 MINERALOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2010-10-14 US claimed
EP-2229167-A1 MINERALOCORTICOID RECEPTOR MODULATORS Merck Sharp & Dohme Corp. (US) 2010-09-22 EP claimed
WO-2009078934-A1 MINERALOCORTICOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2009-06-25 WO claimed
US-20060035922-A1 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors PFIZER INC. 2006-02-16 US claimed
EP-1036062-B1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS PFIZER LTD (GB) 2004-01-02 EP claimed
EP-0495250-B1 Cationic 1,3,4 thiadiazole dyes BAYER AG (DE) 1996-01-31 EP claimed
US-5288593-A Photographic material and process comprising a coupler capable of forming a wash-out dye (Q/Q) EASTMAN KODAK COMPANY (US) 1994-02-22 US claimed
US-5279929-A Coupler forms a compound that washes out during development EASTMAN KODAK COMPANY (US) 1994-01-18 US claimed
EP-0577182-A1 Photographic material and process comprising a coupler capable of forming a wash-out dye (Q/Q) EASTMAN KODAK COMPANY (US) 1994-01-05 EP claimed
EP-0576087-A1 Photographic material and process comprising a coupler capable of forming a wash-out dye (Q/C) EASTMAN KODAK COMPANY (US) 1993-12-29 EP claimed
EP-0576089-A2 Photographic material and process comprising a coupler capable of forming a wash-out dye EASTMAN KODAK COMPANY (US) 1993-12-29 EP claimed
EP-0576088-A1 Photographic material and process comprising a coupler capable of forming a wash-out dye (C/C) EASTMAN KODAK COMPANY (US) 1993-12-29 EP claimed
US-5270308-A Hypotensives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-12-14 US claimed
US-5208325-A CATIONIC 1,3,4-THIADIAZOLE DYESTUFFS BAYER AKTIENGESELLSCHAFT (DE) 1993-05-04 US claimed
EP-0495250-A1 Cationic 1,3,4 thiadiazole dyes BAYER AG (DE) 1992-07-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035922-A1 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors MAPK1, MAPKAPK5, MAPKAPK3 ALDH1A1 2400/4885RECQL 4179/4885IDO1 1826/4885
US-20100261765-A1 MINERALOCORTICOID RECEPTOR MODULATORS NR3C2, MC2R, NR3C1 ALDH1A1 2350/4885RECQL 4642/4885IDO1 4350/4885
US-10221197-B2 Phosphatidylinositol 3-kinase inhibitors PIK3CA, AKT3, PIK3CD ALDH1A1 4535/4885RECQL 631/4885IDO1 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.